ECSS
ZBH icon

Eurizon Capital SGR SpA’s Zimmer Biomet ZBH Stock Holding History

Eurizon Capital SGR SpA’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Sell
175,862
-3,384
-2% -$297K 0.04% 279
2026
Q1 		$16.2M Buy
+179,246
New +$16.4M 0.05% 258

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Eurizon Capital SGR SpA's ZBH Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Zimmer Biomet (ZBH) stake by 1.9% in Q2 2026, selling an estimated $297K and leaving 175,862 shares worth $15.1M. The position accounts for 0.04% of the portfolio, ranked #279.

Eurizon Capital SGR SpA first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. The position peaked at $16.2M in Q1 2026. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Eurizon Capital SGR SpA held 175,862 shares of Zimmer Biomet worth $15.1M as of Q2 2026.
  • Eurizon Capital SGR SpA sold 3,384 Zimmer Biomet shares in Q2 2026, an estimated $297K.
  • Zimmer Biomet made up 0.04% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #279 holding.
  • Eurizon Capital SGR SpA first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
  • Eurizon Capital SGR SpA's Zimmer Biomet position peaked at $16.2M in Q1 2026.
  • 904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.